512 related articles for article (PubMed ID: 28139439)
1. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.
Raife TJ; Cao W; Atkinson BS; Bedell B; Montgomery RR; Lentz SR; Johnson GF; Zheng XL
Blood; 2009 Aug; 114(8):1666-74. PubMed ID: 19541819
[TBL] [Abstract][Full Text] [Related]
3. Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from ADAMTS-13.
Lancellotti S; De Filippis V; Pozzi N; Oggianu L; Rutella S; Scaglione GL; Maset F; Peyvandi F; Mannucci PM; De Cristofaro R
J Thromb Haemost; 2011 Aug; 9(8):1620-7. PubMed ID: 21605335
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic expression of ADAMTS13 in glomerular endothelial cells.
Tati R; Kristoffersson AC; Ståhl AL; Mörgelin M; Motto D; Satchell S; Mathieson P; Manea-Hedström M; Karpman D
PLoS One; 2011; 6(6):e21587. PubMed ID: 21720563
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
[TBL] [Abstract][Full Text] [Related]
6. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
7. PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.
Tull SP; Bevins A; Kuravi SJ; Satchell SC; Al-Ani B; Young SP; Harper L; Williams JM; Rainger GE; Savage CO
PLoS One; 2012; 7(8):e43916. PubMed ID: 22952809
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
9. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
[TBL] [Abstract][Full Text] [Related]
10. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers.
Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL
Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569
[TBL] [Abstract][Full Text] [Related]
12. [ADAMTS13, von Willebrand factor specific cleaving protease].
Veyradier A; Coppo P
Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
[TBL] [Abstract][Full Text] [Related]
13. Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.
Bettoni S; Galbusera M; Gastoldi S; Donadelli R; Tentori C; Spartà G; Bresin E; Mele C; Alberti M; Tortajada A; Yebenes H; Remuzzi G; Noris M
J Immunol; 2017 Aug; 199(3):1021-1040. PubMed ID: 28652401
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions.
Matsunari Y; Sugimoto M; Doi M; Matsui H; Kawaguchi M
Int J Hematol; 2016 Dec; 104(6):661-668. PubMed ID: 27562418
[TBL] [Abstract][Full Text] [Related]
15. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
Akyol O; Akyol S; Chen CH
Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
[TBL] [Abstract][Full Text] [Related]
16. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
18. Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase.
O'Donoghue AJ; Jin Y; Knudsen GM; Perera NC; Jenne DE; Murphy JE; Craik CS; Hermiston TW
PLoS One; 2013; 8(9):e75141. PubMed ID: 24073241
[TBL] [Abstract][Full Text] [Related]
19. Control of von Willebrand factor multimer size and implications for disease.
Pimanda J; Hogg P
Blood Rev; 2002 Sep; 16(3):185-92. PubMed ID: 12163004
[TBL] [Abstract][Full Text] [Related]
20. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
